6th _edition

CAHOCON 2022

Welcome to the exciting 6th edition of the International Conference of CAHO.

at Grand Hyatt Kochi

on 1-3 April 2022

<We_can_help/>

What are you looking for?

>Workshop >Antimicrobial Stewardship (Advanced)

Antimicrobial Stewardship (Advanced)

1st April 2022
from 8:30 am till 5:00 pm IST

at

Aster Medcity, Kochi

 

 

 

 

A survey was conducted to ascertain the practice of antimicrobial stewardship programme (AMSP) in India for 2013. A total of 20 health care institutions (HCI) responded to a detailed questionnaire. All the institutions contacted were tertiary care HCI, of which 12 were funded by the government (GHCI) and 8 were corporate private HCI (FHCI). Further, all catered to both rural and urban populations and were spread across the country. Written documents were available with 40 % for AMSP. 75% for hospital infection control (HIC) and HIC guidelines and 65% for antimicrobial agents (AMA) prescription guidelines.

Records were maintained for healthcare-associated infections (HCAI) by 60% HCI. Antimicrobial resistance (AMR) data were being analyzed by 80% HCI. AMA usage data were analyzed by only 25% HCI and AMA prescription audit and feedback by 30%. PHCI performed better than GHCI across all fields of AMSP. The main contributory factor was possibly the much higher level of accreditation of PHCI hospitals and their diagnostic laboratories. The absence of infectious diseases physicians and clinical pharmacists is worrying and demands careful attention.

India was the largest consumer of antibiotic in 2010, with a 23% increase in retail antibiotic sale among BRICS countries. Fluoroquinolones and 3rd gen cephalosporin have a >70% resistance in Acinetobacter baumannii, E Coli and Klebsiella pnuemoniae and >50% in Pseudomonas aeruginosa. There is also use of antibiotics in animals and food products and effluents from pharmaceutical industry. One of the reason for this is the presence of different health systems in India.

Highlights:

  • AMS: Interpreting Society Guidelines
  • Clinicians’ challenges (Paper to practice to bedside)
  • AMS in challenging situations (MDRO, culture-negative, lack of microbiology support)
  • Antifungal Stewardship
  • AMS: How to present a business case to the management
  • Stewardship Indicators
  • Group exercises, case studies & discussion

 

Who should attend:
Microbiologists, ID Physicians, Infection Control Nurses, Clinical Pharmacologists, Clinical Administrators, Quality Managers, Clinicians-Broad Specialities and Super Specialities, Senior Nurses/Nursing Leaders, Nurses from critical areas, OT

Faculty:
Dr Sankar Sengupta
Medical Superintendent &amp; HOD Laboratory services
Chittaranjan National Cancer Institute

 

Dr Sanjeev Singh
Medical Director, AIMS Faridabad
Chief Medical Superintendent, AIMS Kochi

 

Dr Anup R Warrier
Sr. Consultant Infectious Diseases &amp; Chief of Medical Services
Aster Medcity, Kochi

 

Registration Fees (inclusive of 18% GST):

  • Non Members: ₹ 2000
  • CAHO Members: ₹ 1500

 

For more information, contact:

Ms Akshayaa T:  +91-8111998109

Ms Rosmy Mathew: +91-9539965461

Help Desk : +91 98703 18781